Structure

Physi-Chem Properties

Molecular Weight:  530.16
Volume:  523.572
LogP:  4.473
LogD:  3.283
LogS:  -4.028
# Rotatable Bonds:  3
TPSA:  160.07
# H-Bond Aceptor:  9
# H-Bond Donor:  7
# Rings:  6
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.201
Synthetic Accessibility Score:  4.217
Fsp3:  0.2
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.116
MDCK Permeability:  5.649516879202565e-06
Pgp-inhibitor:  0.041
Pgp-substrate:  0.055
Human Intestinal Absorption (HIA):  0.073
20% Bioavailability (F20%):  0.988
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.011
Plasma Protein Binding (PPB):  97.54158782958984%
Volume Distribution (VD):  0.438
Pgp-substrate:  3.3496663570404053%

ADMET: Metabolism

CYP1A2-inhibitor:  0.046
CYP1A2-substrate:  0.349
CYP2C19-inhibitor:  0.528
CYP2C19-substrate:  0.055
CYP2C9-inhibitor:  0.881
CYP2C9-substrate:  0.995
CYP2D6-inhibitor:  0.291
CYP2D6-substrate:  0.538
CYP3A4-inhibitor:  0.239
CYP3A4-substrate:  0.525

ADMET: Excretion

Clearance (CL):  11.601
Half-life (T1/2):  0.79

ADMET: Toxicity

hERG Blockers:  0.137
Human Hepatotoxicity (H-HT):  0.104
Drug-inuced Liver Injury (DILI):  0.616
AMES Toxicity:  0.279
Rat Oral Acute Toxicity:  0.94
Maximum Recommended Daily Dose:  0.989
Skin Sensitization:  0.956
Carcinogencity:  0.101
Eye Corrosion:  0.003
Eye Irritation:  0.895
Respiratory Toxicity:  0.206

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC277331

Natural Product ID:  NPC277331
Common Name*:   (2S)-4',5,7-Trihydroxyflavan-(4Beta->8)-Afzelechin
IUPAC Name:   (2R,3S)-8-[(2S,4R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-4-yl]-2-(4-hydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol
Synonyms:  
Standard InCHIKey:  FWNROEJRQURIKY-VGGRNRAKSA-N
Standard InCHI:  InChI=1S/C30H26O9/c31-16-5-1-14(2-6-16)25-12-20(27-22(35)9-18(33)10-26(27)38-25)28-23(36)13-21(34)19-11-24(37)29(39-30(19)28)15-3-7-17(32)8-4-15/h1-10,13,20,24-25,29,31-37H,11-12H2/t20-,24+,25+,29-/m1/s1
SMILES:  c1cc(ccc1[C@@H]1C[C@H](c2c(cc(cc2O1)O)O)c1c(cc(c2C[C@@H]([C@@H](c3ccc(cc3)O)Oc12)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2335722
PubChem CID:   71521862
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001586] Biflavonoids and polyflavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO5183 Feretia apodanthera Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[23268742]
NPO16874 Campsiandra guayanensis Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[23268742]
NPO16874 Campsiandra guayanensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO5183 Feretia apodanthera Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT301 Individual Protein Vascular endothelial growth factor receptor 1 Homo sapiens IC50 = 15000.0 nM PMID[524821]
NPT83 Cell Line MCF7 Homo sapiens IC50 > 70000.0 nM PMID[524821]
NPT15 Cell Line Jurkat Homo sapiens IC50 > 70000.0 nM PMID[524821]
NPT4535 Individual Protein Vascular endothelial growth factor A Homo sapiens Kd = 16.0 nM PMID[524821]
NPT4536 Individual Protein Placenta growth factor Homo sapiens Kd = 11.0 nM PMID[524821]
NPT301 Individual Protein Vascular endothelial growth factor receptor 1 Homo sapiens IC50 = 50000.0 nM PMID[524821]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 9.79 ug PMID[524821]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI = 56.19 % PMID[524821]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC277331 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC100482
0.9638 High Similarity NPC248053
0.9638 High Similarity NPC155564
0.9638 High Similarity NPC102280
0.9635 High Similarity NPC475492
0.9568 High Similarity NPC202742
0.9568 High Similarity NPC82917
0.9568 High Similarity NPC70409
0.9568 High Similarity NPC18185
0.9568 High Similarity NPC170103
0.9568 High Similarity NPC236202
0.9568 High Similarity NPC58190
0.9568 High Similarity NPC204770
0.9568 High Similarity NPC262911
0.9568 High Similarity NPC108811
0.9568 High Similarity NPC294558
0.9568 High Similarity NPC263940
0.9496 High Similarity NPC96576
0.9433 High Similarity NPC211561
0.9362 High Similarity NPC20757
0.9362 High Similarity NPC227516
0.9338 High Similarity NPC470308
0.9338 High Similarity NPC470307
0.9301 High Similarity NPC259707
0.9301 High Similarity NPC471403
0.927 High Similarity NPC475836
0.9265 High Similarity NPC471522
0.9259 High Similarity NPC476615
0.9259 High Similarity NPC476617
0.9259 High Similarity NPC476616
0.9236 High Similarity NPC279406
0.9236 High Similarity NPC44192
0.9236 High Similarity NPC469944
0.9236 High Similarity NPC226809
0.9236 High Similarity NPC46283
0.9236 High Similarity NPC134911
0.9236 High Similarity NPC322899
0.9236 High Similarity NPC226108
0.9236 High Similarity NPC272552
0.9231 High Similarity NPC477612
0.9214 High Similarity NPC28440
0.9214 High Similarity NPC171932
0.9179 High Similarity NPC103799
0.9172 High Similarity NPC224161
0.9172 High Similarity NPC20050
0.9172 High Similarity NPC306267
0.9137 High Similarity NPC178054
0.911 High Similarity NPC46335
0.9103 High Similarity NPC59692
0.9085 High Similarity NPC215678
0.9085 High Similarity NPC274454
0.9051 High Similarity NPC125579
0.9044 High Similarity NPC92805
0.9021 High Similarity NPC174251
0.9021 High Similarity NPC153182
0.8986 High Similarity NPC262585
0.8986 High Similarity NPC20829
0.8986 High Similarity NPC18189
0.8978 High Similarity NPC124085
0.8978 High Similarity NPC117048
0.8955 High Similarity NPC53986
0.8955 High Similarity NPC38664
0.8955 High Similarity NPC274717
0.8929 High Similarity NPC262189
0.8926 High Similarity NPC4809
0.8926 High Similarity NPC73517
0.8926 High Similarity NPC147743
0.8921 High Similarity NPC474687
0.8905 High Similarity NPC85435
0.8905 High Similarity NPC77196
0.8897 High Similarity NPC207892
0.8897 High Similarity NPC300875
0.8897 High Similarity NPC17343
0.8897 High Similarity NPC164804
0.8897 High Similarity NPC196765
0.8897 High Similarity NPC206224
0.8897 High Similarity NPC150011
0.8897 High Similarity NPC118114
0.8897 High Similarity NPC129106
0.8897 High Similarity NPC164574
0.8897 High Similarity NPC293203
0.8897 High Similarity NPC280653
0.8897 High Similarity NPC211413
0.8897 High Similarity NPC268917
0.8897 High Similarity NPC129784
0.8897 High Similarity NPC236014
0.8897 High Similarity NPC228369
0.8897 High Similarity NPC118683
0.8897 High Similarity NPC12875
0.8897 High Similarity NPC476166
0.8897 High Similarity NPC68205
0.8897 High Similarity NPC244888
0.8889 High Similarity NPC93962
0.8872 High Similarity NPC167571
0.8872 High Similarity NPC278552
0.8872 High Similarity NPC207179
0.8867 High Similarity NPC471404
0.8867 High Similarity NPC151474
0.8867 High Similarity NPC205613
0.8867 High Similarity NPC86630
0.8867 High Similarity NPC185231
0.8867 High Similarity NPC159526
0.8867 High Similarity NPC106601
0.8867 High Similarity NPC212614
0.8849 High Similarity NPC141717
0.8849 High Similarity NPC3049
0.8844 High Similarity NPC233467
0.8841 High Similarity NPC473107
0.8841 High Similarity NPC296915
0.8841 High Similarity NPC223008
0.8841 High Similarity NPC198154
0.8841 High Similarity NPC115335
0.8841 High Similarity NPC225696
0.8841 High Similarity NPC97834
0.8832 High Similarity NPC13005
0.8828 High Similarity NPC281549
0.8824 High Similarity NPC470225
0.8824 High Similarity NPC27187
0.8819 High Similarity NPC14468
0.8819 High Similarity NPC260397
0.8815 High Similarity NPC222572
0.8815 High Similarity NPC87224
0.8811 High Similarity NPC15659
0.8811 High Similarity NPC304894
0.8811 High Similarity NPC225445
0.8811 High Similarity NPC473108
0.8806 High Similarity NPC230479
0.8806 High Similarity NPC276212
0.8806 High Similarity NPC283049
0.8806 High Similarity NPC50315
0.8806 High Similarity NPC26879
0.8803 High Similarity NPC230718
0.8803 High Similarity NPC5253
0.8803 High Similarity NPC49542
0.8803 High Similarity NPC139976
0.8803 High Similarity NPC84207
0.8803 High Similarity NPC472353
0.8803 High Similarity NPC128337
0.8794 High Similarity NPC182509
0.8794 High Similarity NPC174787
0.8794 High Similarity NPC22317
0.8794 High Similarity NPC213607
0.8786 High Similarity NPC474390
0.8786 High Similarity NPC87777
0.8786 High Similarity NPC262328
0.8777 High Similarity NPC11727
0.8777 High Similarity NPC15109
0.8767 High Similarity NPC321657
0.8767 High Similarity NPC318373
0.8759 High Similarity NPC162801
0.8759 High Similarity NPC181497
0.8759 High Similarity NPC271945
0.875 High Similarity NPC181615
0.8741 High Similarity NPC173203
0.8741 High Similarity NPC116922
0.8741 High Similarity NPC163508
0.8732 High Similarity NPC108674
0.8731 High Similarity NPC103420
0.8731 High Similarity NPC17809
0.8731 High Similarity NPC188022
0.8731 High Similarity NPC102540
0.8731 High Similarity NPC285040
0.8725 High Similarity NPC157333
0.8723 High Similarity NPC260741
0.8723 High Similarity NPC70682
0.8716 High Similarity NPC325860
0.8714 High Similarity NPC470802
0.8705 High Similarity NPC184269
0.8699 High Similarity NPC329836
0.8693 High Similarity NPC12326
0.8681 High Similarity NPC177597
0.8676 High Similarity NPC39064
0.8676 High Similarity NPC47283
0.8671 High Similarity NPC2613
0.8671 High Similarity NPC59841
0.8671 High Similarity NPC204347
0.8671 High Similarity NPC475891
0.8667 High Similarity NPC262573
0.8667 High Similarity NPC471215
0.8662 High Similarity NPC266197
0.8662 High Similarity NPC20520
0.8662 High Similarity NPC291101
0.8662 High Similarity NPC61783
0.8657 High Similarity NPC197351
0.8657 High Similarity NPC134195
0.8657 High Similarity NPC86502
0.8657 High Similarity NPC246648
0.8657 High Similarity NPC106914
0.8652 High Similarity NPC211549
0.8652 High Similarity NPC48956
0.8649 High Similarity NPC329343
0.8649 High Similarity NPC324517
0.8649 High Similarity NPC321972
0.8643 High Similarity NPC473413
0.8643 High Similarity NPC164787
0.8643 High Similarity NPC79957
0.8643 High Similarity NPC61946
0.8639 High Similarity NPC476969
0.8636 High Similarity NPC63438
0.863 High Similarity NPC474397

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC277331 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9104 High Similarity NPD4907 Clinical (unspecified phase)
0.8955 High Similarity NPD4908 Phase 1
0.8571 High Similarity NPD1610 Phase 2
0.8561 High Similarity NPD1613 Approved
0.8561 High Similarity NPD1612 Clinical (unspecified phase)
0.8273 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.8235 Intermediate Similarity NPD8455 Phase 2
0.8201 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.8134 Intermediate Similarity NPD1548 Phase 1
0.8085 Intermediate Similarity NPD3027 Phase 3
0.8071 Intermediate Similarity NPD2861 Phase 2
0.8039 Intermediate Similarity NPD4380 Phase 2
0.7958 Intermediate Similarity NPD4625 Phase 3
0.7949 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7925 Intermediate Similarity NPD6959 Discontinued
0.7902 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7888 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7888 Intermediate Similarity NPD6166 Phase 2
0.7888 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7881 Intermediate Similarity NPD7212 Phase 2
0.7881 Intermediate Similarity NPD7213 Phase 3
0.7862 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD5124 Phase 1
0.7852 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7829 Intermediate Similarity NPD7447 Phase 1
0.7786 Intermediate Similarity NPD4749 Approved
0.7785 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.777 Intermediate Similarity NPD1091 Approved
0.7758 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7755 Intermediate Similarity NPD4538 Approved
0.7755 Intermediate Similarity NPD4536 Approved
0.7755 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7744 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7736 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.773 Intermediate Similarity NPD8651 Approved
0.7703 Intermediate Similarity NPD5960 Phase 3
0.7703 Intermediate Similarity NPD5588 Approved
0.7673 Intermediate Similarity NPD7768 Phase 2
0.7671 Intermediate Similarity NPD4060 Phase 1
0.7669 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7658 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7635 Intermediate Similarity NPD7097 Phase 1
0.7625 Intermediate Similarity NPD7075 Discontinued
0.7616 Intermediate Similarity NPD6674 Discontinued
0.7576 Intermediate Similarity NPD7228 Approved
0.7532 Intermediate Similarity NPD7411 Suspended
0.753 Intermediate Similarity NPD5844 Phase 1
0.7518 Intermediate Similarity NPD7157 Approved
0.7515 Intermediate Similarity NPD8313 Approved
0.7515 Intermediate Similarity NPD8312 Approved
0.75 Intermediate Similarity NPD5846 Approved
0.75 Intermediate Similarity NPD6516 Phase 2
0.75 Intermediate Similarity NPD1652 Phase 2
0.7485 Intermediate Similarity NPD7074 Phase 3
0.7484 Intermediate Similarity NPD1934 Approved
0.7484 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD5058 Phase 3
0.7452 Intermediate Similarity NPD1653 Approved
0.7451 Intermediate Similarity NPD7466 Approved
0.7438 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7434 Intermediate Similarity NPD1549 Phase 2
0.7426 Intermediate Similarity NPD7843 Approved
0.7425 Intermediate Similarity NPD7054 Approved
0.7421 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7415 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7415 Intermediate Similarity NPD6798 Discontinued
0.7396 Intermediate Similarity NPD6559 Discontinued
0.7388 Intermediate Similarity NPD2684 Approved
0.7381 Intermediate Similarity NPD7472 Approved
0.7379 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD7199 Phase 2
0.7375 Intermediate Similarity NPD37 Approved
0.7375 Intermediate Similarity NPD6801 Discontinued
0.7362 Intermediate Similarity NPD6234 Discontinued
0.7346 Intermediate Similarity NPD4966 Approved
0.7346 Intermediate Similarity NPD4967 Phase 2
0.7346 Intermediate Similarity NPD4965 Approved
0.7338 Intermediate Similarity NPD3750 Approved
0.7337 Intermediate Similarity NPD6797 Phase 2
0.7333 Intermediate Similarity NPD3787 Discontinued
0.732 Intermediate Similarity NPD2424 Discontinued
0.7317 Intermediate Similarity NPD5494 Approved
0.7313 Intermediate Similarity NPD290 Approved
0.7294 Intermediate Similarity NPD7251 Discontinued
0.7292 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD5403 Approved
0.7273 Intermediate Similarity NPD422 Phase 1
0.7267 Intermediate Similarity NPD8053 Approved
0.7267 Intermediate Similarity NPD6355 Discontinued
0.7267 Intermediate Similarity NPD8054 Approved
0.7267 Intermediate Similarity NPD5735 Approved
0.7251 Intermediate Similarity NPD7808 Phase 3
0.7248 Intermediate Similarity NPD6233 Phase 2
0.7226 Intermediate Similarity NPD4535 Phase 3
0.7226 Intermediate Similarity NPD3892 Phase 2
0.7222 Intermediate Similarity NPD7819 Suspended
0.7211 Intermediate Similarity NPD3018 Phase 2
0.72 Intermediate Similarity NPD5837 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD7040 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD7041 Phase 2
0.7193 Intermediate Similarity NPD7240 Approved
0.719 Intermediate Similarity NPD6099 Approved
0.719 Intermediate Similarity NPD6100 Approved
0.7188 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD5402 Approved
0.7172 Intermediate Similarity NPD6582 Phase 2
0.7172 Intermediate Similarity NPD6583 Phase 3
0.7161 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD3818 Discontinued
0.7152 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD5401 Approved
0.7151 Intermediate Similarity NPD7549 Discontinued
0.7143 Intermediate Similarity NPD5762 Approved
0.7143 Intermediate Similarity NPD6671 Approved
0.7143 Intermediate Similarity NPD6584 Phase 3
0.7143 Intermediate Similarity NPD7266 Discontinued
0.7143 Intermediate Similarity NPD5763 Approved
0.7126 Intermediate Similarity NPD7229 Phase 3
0.7126 Intermediate Similarity NPD6232 Discontinued
0.7124 Intermediate Similarity NPD1510 Phase 2
0.7117 Intermediate Similarity NPD1465 Phase 2
0.7117 Intermediate Similarity NPD2801 Approved
0.7115 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD4628 Phase 3
0.7111 Intermediate Similarity NPD968 Approved
0.7101 Intermediate Similarity NPD7473 Discontinued
0.7099 Intermediate Similarity NPD6072 Discontinued
0.7097 Intermediate Similarity NPD7037 Approved
0.7091 Intermediate Similarity NPD3749 Approved
0.7089 Intermediate Similarity NPD1511 Approved
0.7086 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD3620 Phase 2
0.7081 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7078 Intermediate Similarity NPD2796 Approved
0.7059 Intermediate Similarity NPD3751 Discontinued
0.7055 Intermediate Similarity NPD2982 Phase 2
0.7055 Intermediate Similarity NPD2983 Phase 2
0.7052 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD5061 Approved
0.7051 Intermediate Similarity NPD5062 Approved
0.7044 Intermediate Similarity NPD7446 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD6004 Phase 3
0.7032 Intermediate Similarity NPD6002 Phase 3
0.7032 Intermediate Similarity NPD6005 Phase 3
0.7025 Intermediate Similarity NPD6666 Approved
0.7025 Intermediate Similarity NPD6667 Approved
0.7018 Intermediate Similarity NPD8156 Discontinued
0.7014 Intermediate Similarity NPD5125 Phase 3
0.7014 Intermediate Similarity NPD5126 Approved
0.7013 Intermediate Similarity NPD7033 Discontinued
0.7013 Intermediate Similarity NPD3748 Approved
0.7 Intermediate Similarity NPD7095 Approved
0.7 Intermediate Similarity NPD1512 Approved
0.7 Intermediate Similarity NPD5283 Phase 1
0.6986 Remote Similarity NPD2981 Phase 2
0.6981 Remote Similarity NPD6799 Approved
0.6974 Remote Similarity NPD4140 Approved
0.6974 Remote Similarity NPD2238 Phase 2
0.697 Remote Similarity NPD3817 Phase 2
0.6962 Remote Similarity NPD2677 Approved
0.6959 Remote Similarity NPD3094 Phase 2
0.6959 Remote Similarity NPD8099 Discontinued
0.6959 Remote Similarity NPD8251 Approved
0.6959 Remote Similarity NPD2797 Approved
0.6959 Remote Similarity NPD8252 Approved
0.6954 Remote Similarity NPD8453 Clinical (unspecified phase)
0.6948 Remote Similarity NPD2200 Suspended
0.6948 Remote Similarity NPD7119 Phase 2
0.694 Remote Similarity NPD940 Approved
0.694 Remote Similarity NPD846 Approved
0.6939 Remote Similarity NPD5327 Phase 3
0.6933 Remote Similarity NPD6599 Discontinued
0.6929 Remote Similarity NPD5535 Approved
0.6928 Remote Similarity NPD3882 Suspended
0.6928 Remote Similarity NPD4340 Discontinued
0.6927 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6923 Remote Similarity NPD7030 Discontinued
0.6923 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6918 Remote Similarity NPD3122 Phase 3
0.6913 Remote Similarity NPD3690 Phase 2
0.6913 Remote Similarity NPD3691 Phase 2
0.6903 Remote Similarity NPD6029 Clinical (unspecified phase)
0.6903 Remote Similarity NPD6028 Clinical (unspecified phase)
0.6899 Remote Similarity NPD7003 Approved
0.6893 Remote Similarity NPD4663 Approved
0.6892 Remote Similarity NPD6696 Suspended
0.6892 Remote Similarity NPD3225 Approved
0.6886 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6883 Remote Similarity NPD4097 Suspended
0.6879 Remote Similarity NPD4869 Clinical (unspecified phase)
0.6875 Remote Similarity NPD7741 Discontinued
0.6875 Remote Similarity NPD7390 Discontinued
0.6871 Remote Similarity NPD7458 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data